证券日报网讯 8月12日晚间，宿迁联盛发布公告称，公司使用闲置募集资金购买了交通银行股份有限公 司宿迁分行的理财产品。截至本公告披露日，上述理财产品已到期，公司已收回本金2，000.00万元及 理财收益10.20万元，与预期收益不存在重大差异。 （编辑 李家琪） ...

公司使用闲置募集资金购买了交通银行股份有限公司宿迁分行的理财产品， 具体内容详见公司在上海证券交易所网站（www.sse.com.cn）披露的公告（公告 编号：2025-035）。截至本公告披露日，上述理财产品已到期，公司已收回本金 2,000.00 万元及理财收益 10.20 万元，与预期收益不存在重大差异。 | | | | | | 赎回 | 收益 | | --- | --- | --- | --- | --- | --- | --- | | 受托方名称 | 产品类型 | 产品名称 | 起始日 | 到期日 | 本金 | 金额 | | | | | | | （万元） | （万元） | | 交通银行股份有 | 结构性存 | 交通银行蕴通财富定 | 2025年5 | 2025年8 | 2,000.00 | 10.20 | | 限公司宿迁分行 | 款 | 期型结构性存款98天 | 月6日 | 月12日 | | | 上述产品本金及理财收益均已归还至募集资金账户。具体情况如下： 1 证券代码：603065 证券简称：宿迁联盛 公告编号：2025-047 本公司董事会、全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 ...

证券代码：603065 证券简称：宿迁联盛 公告编号：2025-046 宿迁联盛科技股份有限公司 关于持股 5%以上股东权益变动触及 1%刻度的 提示性公告 5%以上股东宁波梅山保税港区方源智合投资管理合伙企业（有限合伙）及其一致行 动人保证向本公司提供的信息真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： | 权益变动方向 | 比例增加□ | | 比例减少☑ | | --- | --- | --- | --- | | 权益变动前合计比例 | 7.96% | | | | 权益变动后合计比例 | 6.94% | | | | 本次变动是否违反已作出的承 诺、意向、计划 | 是□ | 否☑ | | | 是否触发强制要约收购义务 | 是□ | 否☑ | | 一、 信息披露义务人及其一致行动人的基本信息 1.身份类别 投资者及其一致行动人的身份 □控股股东/实际控制人及其一致行动人 ☑其他 5%以上大股东及其一致行动人 □合并口径第一大股东及其一致行动人（仅适用 于无控股股东、实际控制人） □其他______________（请 ...

| 2025-08-05 | 宿迁联盛 | 603065 | 9.21 644.7 70 | 中信证券股份有限 公司总部(非营业 London and and and the | 中国国际金融股份 | | --- | --- | --- | --- | --- | --- | | 交易日期 | 证券简称 | 证券代码 | 成交价(元) 成交金额(万元) 成交量( * ) 买入营业部 | | 卖出营业部 有限公司上海分公 | 8月5日，宿迁联盛大宗交易成交70万股，成交额644.7万元，占当日总成交额的7.18%，成交价9.21元，较市场收盘价9.3元折价0.97%。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603065 证券简称：宿迁联盛 公告编号：2025-045 宿迁联盛科技股份有限公司 关于持股5%以上股东权益变动触及1%刻度的提示性公告 5%以上股东宁波梅山保税港区方源智合投资管理合伙企业（有限合伙）及其一致行动人保证向本公司 提供的信息真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： ■ 一、信息披露义务人及其一致行动人的基本信息 1.身份类别 ■ 2.信息披露义务人信息 ■ 3.一致行动人信息 ■ 二、权益变动触及1%刻度的基本情况 宿迁联盛科技股份有限公司（以下简称："公司"）收到宁波梅山保税港区方源智合投资管理合伙企业 （有限合伙）（以下简称"方源智合"）出具的《关于减持宿迁联盛股份触及1%整数倍的告知函》，方 源智合于2025年7月31日至2025年8月4日期间通过集中竞价的方式减持公司股份数量合计达到602,000 股，占公司总股本的0.14%。方源智合存在一致行动人宁波梅山保税港区方源创盈股权投资合伙企业 （有限合伙），变动后方源智合及其一致 ...

证券代码：603065 证券简称：宿迁联盛 公告编号：2025-045 宿迁联盛科技股份有限公司 关于持股 5%以上股东权益变动触及 1%刻度的提示性 公告 5%以上股东宁波梅山保税港区方源智合投资管理合伙企业（有限合伙）及其一致 行动人保证向本公司提供的信息真实、准确、完整，没有虚假记载、误导性陈述或重大 遗漏。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： | 权益变动方向 | 比例增加□ | | 比例减少☑ | | --- | --- | --- | --- | | 权益变动前合计比例 | 8.11% | | | | 权益变动后合计比例 | 7.96% | | | | 本次变动是否违反已作出的承 诺、意向、计划 | 是□ | 否☑ | | | 是否触发强制要约收购义务 | 是□ | 否☑ | | 一、 信息披露义务人及其一致行动人的基本信息 1.身份类别 | | □控股股东/实际控制人及其一致行动人 | | --- | --- | | | ☑其他 5%以上大股东及其一致行动人 | | 投资者及其一致行动人的身份 | □合并口径第一大股东及其一致行动人（仅适用 | | ...

Group 1 - Senyuan Electric signed a strategic cooperation agreement with Xuchang Digital Supply Chain Management Co., aiming for annual business cooperation not exceeding 500 million yuan over 36 months [1] - CICC's subsidiary, CICC Wealth, reported a net profit of 987 million yuan for the first half of the year, with total assets of 193.37 billion yuan [2] - Shuangjie Electric expects a net profit of 100 million to 120 million yuan for the first half of the year, representing a year-on-year increase of 16.03% to 39.23% [3][4] - Shentong Technology reported a net profit of 64.28 million yuan for the first half of the year, a year-on-year increase of 111.09% [5] - Suqian Nongfa's net profit for the first half of the year decreased by 27.72% to 213 million yuan [6] Group 2 - Fuan Pharmaceutical expects a net profit decline of 39.95% to 53.81% for the first half of the year, estimating between 100 million to 130 million yuan [8] - Xingwang Yuda anticipates a net loss of 11 million to 21 million yuan for the first half of the year [9] - Pulaike received a new veterinary drug registration certificate for a vaccine aimed at preventing chicken diseases [10] - Yuandong Biological's ephedrine injection received a drug registration certificate for treating low blood pressure during anesthesia [11] - Suqian Liansheng's subsidiary obtained two invention patent certificates [12] Group 3 - Oke Technology signed a 176 million yuan equipment order with Jiangxi Tianhong New Materials [13] - Publishing Media announced the resignation of its chief accountant due to work changes [15] - Zhongxin Co. plans to use 40 million yuan of idle funds for cash management [16] - Huiyun Titanium plans to use up to 58 million yuan of idle convertible bond funds for cash management [18] - Haineng Technology intends to apply for a credit facility of up to 200 million yuan from a bank [20] Group 4 - Jiabiou expects a net profit increase of 57.61% for the first half of the year, estimating around 107 million yuan [21] - Nanjing Gaoke reported a 1185% year-on-year increase in contract sales area for the second quarter [22] - Shuguang Co. received approval for a specific stock issuance application [23] - Huadong Pharmaceutical's subsidiary received approval for a clinical trial of a new drug targeting advanced solid tumors [23] - Quicheng Co. plans to invest 900 million yuan in two new projects [25] Group 5 - Shenlian Biological's vaccine for avian adenovirus received a new veterinary drug registration certificate [26] - Rike Chemical signed a strategic cooperation framework agreement with Dongming Petrochemical [28] - Jincheng Pharmaceutical's subsidiary received a renewed tobacco production license [29] - Magmi Te's stock issuance application was accepted by the Shenzhen Stock Exchange [29] - Zhongyin Securities received approval to issue bonds totaling up to 14 billion yuan [29] Group 6 - Hewei Electric's executives plan to reduce their holdings by a total of 2.24% of the company's shares [44] - Guo Wang Xintong reported a net profit of 266 million yuan for the first half of the year, a decrease of 10.82% [45] - Guo Wang Xintong's subsidiary won a 966 million yuan tender from the State Grid [46] - Jicheng Electronics won contracts worth approximately 83.79 million yuan from the State Grid [48] - Helen Piano is planning a change of control, leading to a temporary stock suspension [48]

一、发明专利证书基本情况 证券代码：603065 证券简称：宿迁联盛 公告编号：2025-044 宿迁联盛科技股份有限公司 关于全资子公司取得发明专利证书的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 宿迁联盛科技股份有限公司（以下简称"公司"）全资子公司宿迁盛瑞新材 料有限公司于近期取得 2 项国家知识产权局颁发的发明专利证书。具体情况如下： | 序 | 发明名称 | 专利号 | 专利申请 | | 授权公告 | 专利权 | 专利权期 | | --- | --- | --- | --- | --- | --- | --- | --- | | 号 | | | 日 | | 日 | 人 | 限 | | 1 | 一种利用金属铝负载的 大孔磺酸型树脂催化剂 制备 阻聚剂的合成 706 | ZL 2022 1 1472839.6 | 2022 月 11 | 年 23 | 2025 年 月 07 15 | 宿迁盛 瑞新材 料有限 | 20 年（自 申请日起 | | | 方法 | | 日 | | 日 | 公司 | 算） | | 2 | ...

Company and Industry Summary Company Overview - The company is a large enterprise established in March 2011, with a registered capital of 418.97 million yuan and covering an area of approximately 1,600 acres. It was listed on the Shanghai Stock Exchange in March 2023. The company specializes in chemical research and development, production, sales, and technical trade, and is a major producer in the global market for various chemical products [1] Key Financial Metrics - For the fiscal year 2024, the company reported total assets of 3.398 billion yuan, an increase of 5.32% year-over-year. Operating revenue reached 1.504 billion yuan, up 6.11% year-over-year, with main business revenue at 1.496 billion yuan, reflecting a 6.30% increase [2] - The company's main business costs were 1.293 billion yuan, which increased by 13%. The net profit attributable to shareholders was 39.36 million yuan, a significant decline of 47.59% year-over-year. The profit excluding non-recurring gains and losses was 22.11 million yuan, down 65.17% [2] Market Performance - Domestic sales in China amounted to 748.08 million yuan, a rise of 15.89% year-over-year, while international sales were 748.28 million yuan, showing a decline of 1.75% [3] - The chemical industry segment saw a decrease in sales by 7.82%, while the equipment industry experienced a substantial increase in revenue by 221.68% [3] Product Performance - The sales volume of the main product, the hindered amine light stabilizer, increased by 17.87%, but the selling price decreased by 8.69% due to intense market competition, leading to a decline in gross margin by 4.95 percentage points [4] - The company has optimized production processes to improve efficiency, but the increase in raw material costs (up 5.94% and 10.71% year-over-year) has affected the overall cost structure [3] Recent Developments - In the first quarter of 2025, the company reported operating revenue of 304.65 million yuan, a decrease of 3.09% year-over-year, with a net profit of 781,600 yuan, down 28.72% [4] - The company initiated a share buyback program, repurchasing 3.5267 million shares, representing 0.84% of the total share capital, with a total transaction amount of approximately 25.01 million yuan [5] Dividend Distribution - For the fiscal year 2024, the company declared a cash dividend totaling approximately 54.11 million yuan, with a distribution of 1.00 yuan per ten shares [6]

Group 1 - The major shareholders of Suqian Liansheng (603065.SH) have announced plans to reduce their holdings, with significant stakes held by Fangyuan Zhihuo, Coastal Investment, XGBS Venture Capital, and Bansheng Juyuan [1][2] - Fangyuan Zhihuo plans to reduce up to 12,569,027 shares, representing 3% of the total share capital, during the period from July 31, 2025, to October 31, 2025 [2] - Coastal Investment, XGBS Venture Capital, and Bansheng Juyuan collectively plan to reduce up to 12,690,000 shares, accounting for 3.03% of the total share capital, within the same timeframe [2] Group 2 - Suqian Liansheng was listed on the Shanghai Stock Exchange on March 21, 2023, with an issuance of 41.9 million shares at a price of 12.85 yuan per share [3] - The stock reached its highest price of 22.39 yuan on March 23, 2023, but has since experienced a decline and is currently trading below its initial offering price [3] - The total funds raised from the IPO amounted to 538.415 million yuan, with a net amount of 466.6271 million yuan allocated for the construction of products such as light stabilizers and key intermediates [3]